Home / World Marketplace / Archive by category Global Health & Biotech (Page 2)

Archive by category Global Health & Biotech

Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC

SHANGHAI, Nov. 24, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the JS001sc-002-III-NSCLC study has met its primary endpoints. JS001sc-002-III-NSCLC is a multi-center, open-label, randomized Phase 3 clinical study comparing toripalimab [...]

Unlock Practice Growth: Experience cvi42 at RSNA 2025

See Why Leading Radiologists Are Upgrading to cvi42 This November – Visit Circle at RSNA Booth #7961 Highlights The latest release of cvi42 v6.4 focuses on workflow efficiency and leveraging artificial intelligence In-house post-processing speeds reporting time and captures more reimbursement Circle’s vascular capabilities expand with the addition of cvi42 | Vascular CT New business models increase [...]

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

November 24, 2025 New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, web diagnostic viewer [1] that [...]

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation – built for transparency, automation, [...]

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December

TEL AVIV, Israel, Nov. 21, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, and other members of executive management will present at three upcoming investor conferences in December as follows: 8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. [...]

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

The 17th edition of the renowned series convenes international researchers and healthcare providers, sharing new insights in lactation science, neonatal care, and human milk research Baar, Switzerland, Nov. 20, 2025 (Korea Bizwire) – Medela, a global leader in breast milk and healthcare technology, continues its legacy of advancing lactation science and clinical education through its 2025 Global Breastfeeding [...]

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa $7 billion, representing the largest transaction in nuclear medicine globally The recapitalization will accelerate Curium’s strategy to launch innovative, life-changing diagnostic and therapeutic solutions for cancer patients around the world BOSTON, Nov. 20, 2025 (Korea [...]

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted positive opinions for two Boehringer poultry vaccines against the highly pathogenic H5 avian influenza virus1. VAXXITEK® HVT+IBD+H5 is the first trivalent vaccine offering combined protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in chickens and turkeys in one single [...]

New Global Study: Dangerous Nighttime Heat Rising in 83% of Global Cities Analyzed, Becoming More Oppressive, And More Frequent

WASHINGTON, Nov. 19, 2025 (Korea Bizwire) – While leaders have been focusing on avoiding breaching the +1.5°C threshold of the Paris Agreement, a sweeping new scientific analysis of the most dangerous summer weather conditions across 100 major global cities revealed that minimum nighttime temperatures have been rising up to 10 times faster than daytime average [...]

Asia Front and Centre: CAPHRA Powers Regional Voice at GoodCOP 2.0

GENEVA, Nov. 20, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is celebrating the successful “Asia Day” event at the GoodCOP 2.0 held in Geneva. The event, held during the same week as the FCTC COP11 brought together consumer advocates, public health experts, medical professionals, and policymakers to highlight [...]